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found that this hypothesis is not correct", e.g. analogues ofvasopressin* having L-or n-Ala in position 9 display high antidiuretic activity'-", though lower than the parent hormones. In the case of [8-arginine] vasopressin the activities are higher than those of [8-lysine] vasopressin. Besides, n-ulanine substitution in both LVP and A VP conserves certain pressor activity (about 50 times lower than that of 'the parent hormone), in the L-alanine substituted analogues the pressor activity is practically zero. Interestingly, the "design" of analogues (described? and patented", but probably never synthesized") selectively influencing the production of factor VIII was based just on the reported low activity of [Lys", o-Ala 9]VP. This analogue was later synthesized and biologically evaluated either by Gazis''" and by us (see Table I ) and found to be antidiuretically rather potent. Since there is no doubt about its structure (verified by IH and l3C NMR) and purity (TLC, HPLC), the originally reported * All the chirnl amino acids, mentioned in this work. are of the t-serles. The nomenclature and symbols of the amino acids and peptides obey the published recommendations 5; Ace denotes the l-aminocyclopropune-l-cnrboxylic acid moiety.
activities must be considered wrong. Regarding these results we decided to synthesize also the analogue containing L-alanine in position 9, originally synthesized together with [Lys", o-Ala 9]VP. In this case, the activities found with the newly synthesized analogue are very well comparable with the activities reported earlier'.
The differences in biological activities of analogs with 0-or t-alanine in position 9 prompted us to study the influence of this substitution on the conformation of the cyclic part of the molecule. We have measured IH and IJC NMR spectra of both analogs in deuterated dimethylsulfoxide (Tables II and  III) . The comparison of IJC chemical shifts didn't reveal any significant differences between these two compounds. However, in the IH NMR spectrum the differences in chemical shifts were found for C(-CH of Phe (0.09 ppm), P-CH, of Phe (0.07 and 0.09 ppm), P-CH, of Asn (0.07 ppm) and C(-CH of Cys6 (0.15 ppm). The most important seems to be the difference in magnetic nonequivalence ofp-protons of phenylalanine and asparagine and the difference in NH proton chemical shift temperature dependence of these two residues.
The temperature dependence of asparagine NH, which has usually very small or even positive coefficient of temperature dependency 19 is significantly shielded from the interaction with the solvent. All these findings support the idea that the substitution of glycine in position nine influences very importantly the conformation of the cyclic region of the molecule, especially the phenylalanine residue which is known to be important for the expression of vasopressin-like activities.
With the growing interest in the central effects of vasopressin (for the review see ref. 2D), the position 9 gained in significance. The application of CNS activities of the neurohypophyseal hormones is complicated by the high peripheral activities. Therefore, analogues with eliminated classical (antidiuretic, pressor) activities and unchanged potential in influencing the eNS lire valuable. Rather successful in this direction is des-Gly-Nl-I, 9-[Lys8]vasopressin which displays low peripheral acivities and still retains high degree of central effects. Analogues synthesized up to now with the modification in position 9 are reported to lose their activities, especially the pressor activity. There are no reports about their CNS activities.
In order to study more thoroughly the effect of the changes in position 9, we have synthesized analogues of vasopressin containing a non-coded amino acid, l-aminocyclopropane-I-carboxylic acid (Ace) in this position. This amino acid was already used in the syntheses of enkephalin'I.2', oxytocin", and tuftsin" analogues. Ace is achiral as glycine, however, sterically more demanding and it may influence the whole conformation of the C-end of the Three analogues of vasopressin were synthesized contuuung Ace in position 9, Two of these analogues were derived from [8- 
Syntheses of all the three analogues were perfomed by solid phase technique on the benzhydrylamine resin, As an a-amino group protection we have used tert. butyloxycarbonyl group with the exception of Ace where benzyloxycarbonyl group was used, For the side chain protection we have used: 2-bromobenzyloxycarbonyl (Lys), tosyl (Arg), benzyl (Tyr), 4-methylbenzyl (Cys). Protected amino acids were coupled by N,N'-dicyclohexylcarbodiimide (DCC) and N-hydroxybenzotriazole (HOBt) in dimethylformamide. Benzyloxycarbonyl group was cleaved by hydrogen bromide in acetic acid-dichlcromethane mixture. Side chain protecting groups were cleaved simultaneously, with the cleavage of the peptide from the resin by liquid hydrogen fluoride. Sulfhydryl groups oxidation was performed by potassium ferricyanide and analogues were purified by HPLC and gel filtration.
[L-Ala 9]L VP was prepared in a similar way. Biological activities of the analogues containing Ace in position 9 are given in the Table 1 . According to the pressor activity, it may be stated that Ace resembles L-alanine in the position 9, which means an almost complete elimination of the activity. Analogue I exhibits also a comparable antidiuretic activity to t-Ala containing analogue. On the other hand, analogue of AVP with Ace in position 9 has a significantly diminished antidiuretic activity in comparison to either L-or D-Ahl containing analogues. It should be noted that modification in position 9 exerts quite different influence on the activities depending on the basic amino acid in the position 8. These modifications have much more pronounced (usually activity decreasing) effect in the LVP series than in the AVP one. The influence of the substitutions in other positions of the peptide chain is usually much more similar in both series. Therefore, one can conclude that the stimulation of the appropriate receptor (mainly the V2) is performed by the side chain of the amino acid in position 8 and the carboxy-terminal amino acid in cooperation.
In the tests for antidiuretic activity on unanaesthetized animals no differences between the LVP and AVP analogues have been found. Analogue with the backbone prolonged by three glycine residues had higher antidiuretic activity in this test than in the test on anaesthetized rats. Oxytocin-like activities of all the compounds were significantly decreased.
The new compounds did not show any analgetic or sedative activity in tail-nick or hot plate tests at doses 20 ug per mouse. Analogs II and III were tested also in the passive and active avoidance tests. No effect on memory after subcutaneous injection of 3 and 5~lg/kg was observed in rats (SPF Wistar and Long Evans).
In conclusion it may be summarized that the introduction of Ace into the position 9 of vasopressin leads to a selectively acting antidiuretic agonist with low potency and no effect on the CNS activity. Comparison of the influence of Ace substitution on pressor and antidiuretic activities in Iysine-and arginine-vasopressin series suggests that. the conformational restriction produced by I-aminocyclopropane-I-carboxylic acid might be the same as that caused by t-alanine,
EXPERIMENTAL

General methods
Thin-layer chrcmatogruphy (TLC) was carried out on silica gel coated plates (Silufoi, Kavnller, Czechoslovakin) in the following systems: 2:-but<lnol-98% formic acid-water (10 : 3 : 8) (S1), l-butunol-ucctic acid-water-pyridine (15: 3: 6: 10) (S4), l-butanol-acetic acid-water (50: 15: 40) (SI3). Paper electrophoresis was performed in a moist chamber in I M acetic acid (pl-l 2.4) and in pyridine-acetate buffer (pl-l 5.7) on Whatman 3MM paper at 20 V/cm for 60 min. Spots in TLC and electrophoresis were detected with ninhydrin or by chlorination method. Samples for amino acid analyses were hydrolyzed with 6 M: HCI at 105°C for 20 h or with a mixture propionic acid-hydrochloric acid (I : I) at l60 uC for 15 min and analyzed 011 I.In Amino acid analyzer T 339 (Mikrotechna Pruha. Czechoslovakia) or D~500 analyzer (Durrum Corp., U.S.A.). Optical rotations were determined on a Perkin-Elmer Instrument type 141 MeA (Norwalk, U.S.A.). Fast atom bombardment mass spectra were obtained on a ZAB~EQ spectrometer (VG Analytical Ltd., Manchester) with xenon at 8 kV as the bombarding gas. Proton ID-NMR spectra. a homonuelear IH_II-1 correlated 20 COSY spectra und a curbon-l J 10-NMR spectra were measured on a Bruker AM-400 (at 400.13 MHz rcsp. 100.6 MHz) instrument in hcxadeuterlodlmethylsulfoxlde. High performance liquid chromatography (HPLC) was carried out on an SP-8700 instrument equipped with an SP~8400 detector and SP-4100 integrator (all from Spectra Physics, Santa Clara, U.S.A.). Preparative liquid chromatography was carried out on a f\:1QP1.l;lprep preparative liquid chromatograph (Jobin Yvou. Longjumeau Cedex, France). As the final purification step, the Biogel P-2 column chromutogruphy (I x 100 em) in I M acetic acid was used. Cheluton III was added to the sample in order to remove the traces of heavy metals if present. Before usc, all amino-acid derivatives were subjected to the ninhydrin test::!H.
Solid-phuse peptide synthesis
A cycle for incorporation of each amino acid residue into the growing peptide chain consisted of the following steps: I, washing with dichloromcthanc (3 x 20 ml, l min/wash): 2, cleavage the Bee group by 20 ml or 45% trifluorncetic acid in dlchlorornethuue containing 5% anisole, one treutmcnt for 5 min, a second onc for 30 min; 3, washing with dichloromcthanc (3 x 20 ml, I min/wash): 4.
Prochazka ct ul.:
washing with isopropanol (3 x 20 mi. I min/wash); 5, washing with dichlorometbune (3 x 201111.
I min/wash); 6. ucutrulizing by 5%1 diisopropylcthylaminc in dichloromcthnuc (2 x :W mi.
2: min/wash): 7. washing with dichlorcmcthanc (4 x 20 mi. I min/wash); 8. washing with dirncthylformamidc (3 x 20 mi. 1 min/wash); 9. adding the Bee-protected amino acid derivative in 20 Ill! of dimcthylformamidc followed by HOBt, followed by DeCI and stirring for 30 min-16 11: 10, washing with dimcthylformumide (3 x 20 ml, I min/wash); II, washing with dichloromethane (3 x 20 ml, lminjwash). Between the steps 9 and 10, scvcral milligrurns of' the resin were removed and used lor the ninhydrin tesr" to determine the progress of the coupling. In the case of the coupling on the imino group ofprolinc the chloranil test 2lJ was used. The synthesis Of[L~AlalJ]LVP WI.IS monitored by the bromophenol blue ("BB") rnctbcd".
Nonupcptidc-rcsin (Peptide-resin A)
The bcuzhydryluminc resin (UeB, 0.6 mmol/g, 0.83 g) was suspended in dichloromcthnnc uud was coupled with u three-molar excess of N'i-beuzyloxycarbonyl-1-aminccyclopropnuc-I-curboxylic acid]l in the presence of Nchydroxybcnzotriazole and dicyclchexylcarbodiimide in dintethylformumide. The coupling was interrupted after 2 h, the resin was washed consequently by dimethylformamidc (3 x 20 ml) and dichlorcmcthanc (3 x 20 ml) and free amino groups were acctylated. The acetylation mixture I (5 ml acetunhydride, 2: ml triethylamine in 50 ml dichloromethunc) was used at the beginning. Since the acetylation was not complete even after 2-4 h, acetylation mixture II (4 ml acetanhydride, 6 ml triethylamine in 50 ml dichlorornethane) was used and the free amino groups disappeared during two hours (according to the ninhydrin test).
The bcnzyloxycarbonyl protecting group was cleaved from Nvbenzylcxycarbonyl-I -uminocyclopropane-I-curboxy-rcsiu by 35% I-IBr in acetic acid in the mixture with dichlorometliane (I : I) during 15 min. The following procedure was performed according to n general scheme (sec abovẽ starting from the point 3.). Bee-amino acids were coupled to the resin by the DCCI/HOBt procedure. All reagents were used in three-molar excess and coupling was monitored by the ninhydrin test. The protected derivatives were used in the following order: Boe-Lys(2-Br-Z)~OH3~.
Boc-Pro-OH, Boe-Cys(4-Mc-Bzlj-OH", Boc-Asn-OH, Boe-Gln-OH. Boo-Phc-Ol-l. Boe-Tyr(Bzl)-OH and Bcc-Cysia-Mc-Bzlj-Ol'I. The Boc-Tyrt Bzlj-Ol-l was released before usc from its dicyclohexylamonium salt. In the case of proline and glutamine coupling, the reaction was not complete even after 20 h, thus one equivalent of a nucleophilic acylation catalyst (4-dimethylaminopyridine) was used. Finally, the Bee-group was cleaved from the nonapeptide--rcsin, resin was washed and dried. Yield: 0.8Sg.
The peptide-resin A (0,42g, 0.25 mmcl) was treated with liquid hydrogen fluoride (10 ml, 60 min, OllC) in the presence of thiouuisclc (I ml). The unprotected nonapeptide, together with the resin, was triturated with ethyl acetate after the evaporation of hydrogen fluoride, filtered off, washed with ethyl acetate and then free peptide was extracted successively by acetic acid, 50% acetic acid, water and lyophilized. The lyophilizate was dissolved in water (150 ml) and the pH of the solution was adjusted with 0.1 M NaOI-I to 7.0. Potassium fcrricyanide (65 mg in 30 ml of water) was added to this solution in a course of 10 min. During the oxidation (20 min), the pH was maintained at 7.0 by addition of O. I M NaOI-I and then adjusted with acetic acid to 4.5. The solution was applied on a column ofAmberlite CG~50I, the column was washed with 0.25% acetic acid and the product eluted with 50% acetic acid. After freeze-drying, the product (52.6 mg) was purified by HPLC (Sepuron SIX C-18, 7 um, 25 x 0.8 em). Elution with methanol-O.05% trifluoroacctic ucid mixture (3 : 7) and lyophilization of the corresponding fractions afforded 10.5 mg of the product pure according to IIPLC (k' 5.87; methanol-0.05";;) u-ifluoroncotic ucid 3 : 7) . This product was filtered The benzhydrylumine rcsin (UeB. 0.6 mmol/g, 1.66 g) was suspended in dichloromcrhuue and lifter washing with dimcthylformamidc it wascoupled with a three-molarexcess of N'l-bellzyloxycarbonyl-Iaminocyclopropnnc-l-carboxyllc ucid", Nchydrcxybcnzotriazolc and dicyclohexylcarbodiimidc in dimcthylfonnamide. The coupling was interrupted after 2 h, the resin waswashed consequentlywith dimcthylformamlde (3 x 20 ml) and dichloromcthane (3 x 20 ml) and free amino groups were uccrylatcd with the mixture of 4 ml ucetunhydride lind 6 ml triethylamine in 50 ml dichlororncthane. The free amino groups disuppearcd during 90 min (according to the' ninhydrin test).
The bcnzyloxycarbonyl protecting group Was cleaved from Nf-bcnzyloxycarbonyl-Luminocyclopropane-Lcarbcxy-resin by 35% HBrinacetic acidinthemixture withdichlcromethane (1 : I) during 15 min. The following procedure wasthesame as in thecaseof analogue I with theexception of the first step in which Boc-Arg(Tos)-OH was used instead of lysine derivative. Finally, the Bee-group was cleaved from the nonapcptidc-rcsin, resin was washed and dried (2.2 g).
The nona peptide-resin (1.1· g) was treated with liquid hydrogen fluoride (IS rnl, 60 min, DOC) in the presence of thioanisolc (2 ml), The unprotected nonapeptidc ufter workup (see above. 168 mg) was oxidized by potassium ferricyanide (60 mg in 20 ml of water), desalted on U i COIUl1111 of Ambcrlitc CG-SOI and the product (93 mg) was purified by HPLC (Scparon SIX C-18. , .
The benzhydrylaminc resin (Ues. 0.6 mmal/g, 0.67 g) was suspended in dichloromethanc and after washing with SUA> diisopropylcthylaminc in dichloromethauc and with dirnethylformamidc it wus coupled with a two-molar excess of Boc-L-Aln-OH. Nehydroxybeuzotriuzole and dicyclohexylcurbodiirnidc in dimcthylfonnamidc. The coupling was interrupted after 1.5 h, the resin W,\5 washed consequently with dirncthylforrnamidc (3 x 20 rnl) and dichloromcthuue (3 x 20 m1) and free amino groups were ucctylatcd with a mixture of 4 ml ncctnnhydridc and 6 ml triethylamine in 50 m! dichloromcthnno. The free <Iminogroups disappeared during 150 min (according to the ninhydrin test).
The following procedure was performed according to the general scheme (starting from the point 2.). Bee-amino acids were coupled to the resin by the DCCI/HOBt procedure. All reagents were used .in a 3 molar excess and coupling was monitored by bromophenol blue method". The protected derivatives were used in the following order: Boc-Lys(2~BI'-Z)-OH;l.1, Boc-Pro-Ol-l. Boc-Cys(4-Me-Bzl)-OH". Boc-Asn-Ol-l. Boc-Gln-OH. Boe-Phe-OH. Boe-Tyr(2.6-CI,-Bz\)-OH"
and Boc-Cys(4~Me~Bz1)~OH. The coupling was complete during 30 min, but it was always performed for 2 h. Finally. the Bee-group was cleaved from the nonapcptide-resiu. the resin was washed and dried (1.1 g).
The uonapcpttdc-rcsin (1.1 g) was treated with liquid hydrogen fluoride (10 mi. 60 min. DOC) in the presence of thioauisclc (l ml). The unprotected nouapeptide (300 mg) W,\S oxidized by potassium ferricyuuide (l00 mg in 30 ml of water), desalted on a column of Amberlite 
Pharruucologicnl Methods
All pharruacologlcul test were performed using Wistar rats weighing 200-300 g. The uterotonic potency in vitro was evaluated using the Holton procedure" in Munsick" SOlution, and in vivo according to re(\fl. The gulactogogic potency in vivo was established according to refs37.3M. The pressor activity was tested on pithed rat preparation according to refs 39 .40, The antidiuretic potency on anaesthetized rat was followed according to the method in reCIO, The activity on unanaestheuzed rat was evaluated using the modified Burn's method!':". Mule rats (160-200 g), after overnight fasting with free access to water, were applied per as the water load (4 miflOOg) and, simultaneously, a s.c, injection of the tested compound 01' u standard preparation was administered, The urine W. 15 collected for 5 h and its volume was read every 15 min. The time in minutes (T 1 f2) during which the half of water load was excreted was taken as a measure for the deluy of water diuresis. LVP was used as the standard at doses 1.0 a 5.0 mUflOO g in 0.2 mi. Analogues I and III were applied at doses from 20 to 500 ng/iOO g. analogue II from 100 to 1250 ngflOO g. Control ruts were injected with physiological solution.
The tail flick test and the hot plate test were performed according to refs 42 
